Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guangbin Yang

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Molecular Pharmaceutics|May 19, 2026
Establishment of <sup>68</sup>Ga-DOTA-Based Pretargeted RadioimmunodiagnosisDarren R Veach, Daniela Burnes Vargas, Baharul Islam, et al.
Theranostics|October 14, 2020
Alpha radioimmunotherapy using <sup>225</sup>Ac-proteus-DOTA for solid tumors - safety at curative dosesSarah M Cheal, Michael R McDevitt, Brian H Santich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 21, 2024
Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent <sup>177</sup>Lu-Labeled RadiohaptenBrett A Vaughn, Sang-Gyu Lee, Daniela Burnes Vargas, et al.
Science (New York, N.Y.)|February 2, 2019
Opposing reactions in coenzyme A metabolism sensitize <i>Mycobacterium tuberculosis</i> to enzyme inhibitionElaine Ballinger, John Mosior, Travis Hartman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 22, 2023
Efficacy of HER2-Targeted Intraperitoneal <sup>225</sup>Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal CarcinomatosisSebastian K Chung, Daniela Burnes Vargas, Christopher S Chandler, et al.
JAMA Surgery|July 2, 2025
Rizedisben in Minimally Invasive Surgery: A Nonrandomized Clinical TrialSamuel A Gold, Maria M Pere, Melissa Assel, et al.
Cancer Research|January 24, 2012
ARN-509: a novel antiandrogen for prostate cancer treatmentNicola J Clegg, John Wongvipat, James D Joseph, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Molecular Pharmaceutics|May 19, 2026
Establishment of <sup>68</sup>Ga-DOTA-Based Pretargeted RadioimmunodiagnosisDarren R Veach, Daniela Burnes Vargas, Baharul Islam, et al.
Theranostics|October 14, 2020
Alpha radioimmunotherapy using <sup>225</sup>Ac-proteus-DOTA for solid tumors - safety at curative dosesSarah M Cheal, Michael R McDevitt, Brian H Santich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 21, 2024
Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent <sup>177</sup>Lu-Labeled RadiohaptenBrett A Vaughn, Sang-Gyu Lee, Daniela Burnes Vargas, et al.
Science (New York, N.Y.)|February 2, 2019
Opposing reactions in coenzyme A metabolism sensitize <i>Mycobacterium tuberculosis</i> to enzyme inhibitionElaine Ballinger, John Mosior, Travis Hartman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 22, 2023
Efficacy of HER2-Targeted Intraperitoneal <sup>225</sup>Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal CarcinomatosisSebastian K Chung, Daniela Burnes Vargas, Christopher S Chandler, et al.
JAMA Surgery|July 2, 2025
Rizedisben in Minimally Invasive Surgery: A Nonrandomized Clinical TrialSamuel A Gold, Maria M Pere, Melissa Assel, et al.
Cancer Research|January 24, 2012
ARN-509: a novel antiandrogen for prostate cancer treatmentNicola J Clegg, John Wongvipat, James D Joseph, et al.
Pageof 4